Nanjing Huagai Pharmaceutical

Nanjing Huagai Pharmaceutical is a specialized pharmaceutical company based in Nanjing, China, focusing on the research, development, and manufacturing of inhalation therapies for respiratory diseases. The company has established a comprehensive technology platform for complex drug delivery systems, including dry powder inhalers (DPI), pressurized metered-dose inhalers (pMDI), and nebulized liquids. Its primary therapeutic focus is on Chronic Obstructive Pulmonary Disease (COPD) and asthma, with a portfolio that includes several high-demand generic and improved inhalation products. Nanjing Huagai operates state-of-the-art manufacturing facilities that meet international GMP standards to support its growing pipeline of respiratory treatments. The company is recognized for its expertise in overcoming the significant technical barriers associated with complex inhalation drug-device combination products.